KESICKI; Edward A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for KESICKI; Edward A..The latest application filed is for "quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta".

Company Profile

10.49.52

KESICKI; Edward A. - Bothell WA
KESICKI; Edward A. - New York NY
KESICKI; Edward A. - Mill Creek CA
Kesicki; Edward A - Bothell WA
Kesicki; Edward A. - Bothwell WA
Kesicki; Edward A. - Seattle WA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20210332047 - KESICKI; Edward A. ; et al.	2021-10-28
Aminopyridine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20210317136 - LINDSTROM; Johan ; et al.	2021-10-14
Chromenopyridine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20210253600 - LINDSTROM; Johan ; et al.	2021-08-19
Tert-butyl (s)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)prop- yl)carbamate precursor of a quinazolinone inhibitor of human phosphatidylinositol 3-kinase delta and a process for preparing thereof Grant 10,906,907 - Kesicki , et al. February 2, 2	2021-02-02
Aminopyrimidine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20200392156 - KESICKI; Edward A.	2020-12-17
Chromenopyrimidine Derivatives As Phosphatidylinsitol Phosphate Kinase Inhibitors App 20200392162 - KESICKI; Edward A.	2020-12-17
Aryl-bipyridine Amine Derivatives As Phosphatidylinositol Phosphate Kinase Inhibitors App 20200331913 - LINDSTROM; Johan ; et al.	2020-10-22
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 10,695,349 - Sadhu , et al.	2020-06-30
Trpa1 Antagonists For Treatment Of Dry Eye, Ocular Pain And Inflammation App 20200179357 - HERZ; Jeffrey M. ; et al.	2020-06-11
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20200061062 - SADHU; Chanchal ; et al.	2020-02-27
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20200017503 - KESICKI; Edward A. ; et al.	2020-01-16
TRPA1 modulators Grant 10,428,049 - Herz , et al. October 1, 2	2019-10-01
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 10,398,695 - Sadhu , et al. Sep	2019-09-03
(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one precursor of a quinazolinone as inhibitor of human phosphatidylinositol 3-kinase delta Grant 10,336,756 - Kesicki , et al.	2019-07-02
Trpa1 Modulators App 20190016701 - Herz; Jeffrey M. ; et al.	2019-01-17
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20180360832 - SADHU; Chanchal ; et al.	2018-12-20
Spirocyclic Hat Inhibitors And Methods For Their Use App 20180193315 - Kesicki; Edward A. ; et al.	2018-07-12
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 10,010,550 - Sadhu , et al. July 3, 2	2018-07-03
TRPA1 modulators Grant 9,951,046 - Herz , et al. April 24, 2	2018-04-24
Spirocyclic Hat Inhibitors And Methods For Their Use App 20180071262 - Kesicki; Edward A. ; et al.	2018-03-15
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits Grant 9,896,422 - Duncan , et al. February 20, 2	2018-02-20
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20170340633 - SADHU; Chanchal ; et al.	2017-11-30
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits App 20170144979 - Duncan; Iain W. ; et al.	2017-05-25
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20170049772 - SADHU; Chanchal ; et al.	2017-02-23
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits Grant 9,573,912 - Duncan , et al. February 21, 2	2017-02-21
Trpa1 Modulators App 20170001983 - Herz; Jeffrey M. ; et al.	2017-01-05
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 9,487,772 - Sadhu , et al. November 8, 2	2016-11-08
Spirocyclic Hat Inhibitors And Methods For Their Use App 20160235716 - Kesicki; Edward A. ; et al.	2016-08-18
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20160075705 - KESICKI; Edward A. ; et al.	2016-03-17
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits App 20160009668 - Duncan; Iain W. ; et al.	2016-01-14
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits Grant 9,168,265 - Duncan , et al. October 27, 2	2015-10-27
5-fluoro-3-phenyl-2-[1-(9h-purin-6-ylamino)propyl]-3h-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta Grant 9,149,477 - Kesicki , et al. October 6, 2	2015-10-06
5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,993,583 - Fowler , et al. March 31, 2	2015-03-31
5-fluoro-3-phenyl-2[1-(9H-purin-6-ylamino)propyl]-3H-quinazolin-4-one and 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,980,901 - Fowler , et al. March 17, 2	2015-03-17
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20140378479 - KESICKI; Edward A. ; et al.	2014-12-25
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta Grant 8,779,131 - Kesicki , et al. July 15, 2	2014-07-15
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20140154772 - SADHU; Chanchal ; et al.	2014-06-05
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20140121223 - Fowler; Kerry W. ; et al.	2014-05-01
Quinazolinones As Inhibitors Of Human Phosphatidyositol 3-kinase Delta App 20140121224 - FOWLER; Kerry W. ; et al.	2014-05-01
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,653,077 - Sadhu , et al. February 18, 2	2014-02-18
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,637,533 - Sadhu , et al. January 28, 2	2014-01-28
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,623,881 - Sadhu , et al. January 7, 2	2014-01-07
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta Grant RE44,638 - Fowler , et al. December 10, 2	2013-12-10
6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta Grant 8,586,597 - Fowler , et al. November 19, 2	2013-11-19
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta Grant RE44,599 - Fowler , et al. November 12, 2	2013-11-12
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20130231356 - KESICKI; Edward A. ; et al.	2013-09-05
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,492,389 - Sadhu , et al. July 23, 2	2013-07-23
Tetracycline Derivatives With Reduced Antibiotic Activity And Neuroprotective Benefits App 20130123217 - Duncan; Iain W. ; et al.	2013-05-16
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20130116266 - FOWLER; Kerry W. ; et al.	2013-05-09
Xanthones, thioxanthones and acridinones as DNA-PK inhibitors Grant 8,404,681 - Halbrook , et al. March 26, 2	2013-03-26
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits Grant 8,338,477 - Duncan , et al. December 25, 2	2012-12-25
Materials and methods to potentiate cancer treatment Grant 8,242,115 - Halbrook , et al. August 14, 2	2012-08-14
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20120172591 - Sadhu; Chanchal ; et al.	2012-07-05
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,207,153 - Fowler , et al. June 26, 2	2012-06-26
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20120135994 - Sadhu; Chanchal ; et al.	2012-05-31
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 8,138,195 - Sadhu , et al. March 20, 2	2012-03-20
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20120015964 - Fowler; Kerry W. ; et al.	2012-01-19
Heteroaryl urea derivatives useful for inhibiting CHK1 Grant 8,093,244 - Diaz , et al. January 10, 2	2012-01-10
Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta Grant 7,932,260 - Fowler , et al. April 26, 2	2011-04-26
Inhibitors Of Human Phosphatidyl-inositol 3-kinase Delta App 20110021541 - White; Stephen L. ; et al.	2011-01-27
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20100256167 - Fowler; Kerry W. ; et al.	2010-10-07
Quinazolinones As Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20100256168 - Fowler; Kerry W. ; et al.	2010-10-07
Thienopyrimidiones For Treatment Of Inflammatory Disorders And Cancers App 20100216820 - White; Stephen L. ; et al.	2010-08-26
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20100168139 - Sadhu; Chanchal ; et al.	2010-07-01
Inhibitors Of Human Phosphatidylinositol 3-kinase Delta App 20100152211 - SADHU; Chanchal ; et al.	2010-06-17
Compounds Useful For Inhibiting Chk1 App 20100105683 - Keegan; Kathleen S. ; et al.	2010-04-29
Tetracycline Derivatives with Reduced Antibiotic Activity and Neuroprotective Benefits App 20100009981 - Duncan; Iain W. ; et al.	2010-01-14
Urea or thiourea substituted 1,4-pyrazine compounds useful as anti-cancer agents and for inhibiting Chk1 Grant 7,608,618 - Kesicki , et al. October 27, 2	2009-10-27
Heteroaryl Urea Derivatives Useful For Inhibiting Chk1 App 20090143357 - Diaz; Frank ; et al.	2009-06-04
Quinazolinones as Inhibitors of Human Phosphatidylinositol 3-Kinase Delta App 20080275067 - Fowler; Kerry W. ; et al.	2008-11-06
Materials and methods to potentiate cancer treatment App 20080090782 - Halbrook; James ; et al.	2008-04-17
Xanthones, thioxanthones and acridinones as dna-pk inhibitors App 20070167441 - Halbrook; James W. ; et al.	2007-07-19
Materials and methods to potentiate cancer treatment Grant 7,179,912 - Halbrook , et al. February 20, 2	2007-02-20
Cyclic AMP-specific phosphodiesterase inhibitors Grant 7,176,229 - Martins , et al. February 13, 2	2007-02-13
Compounds useful for inhibiting Chk1 Grant 7,067,506 - Keegan , et al. June 27, 2	2006-06-27
Cyclic AMP-specific phosphodiesterase inhibitors App 20060074123 - Martins; Timothy J. ; et al.	2006-04-06
Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,998,416 - Martins , et al. February 14, 2	2006-02-14
Inhibitors of human phosphatidylinositol 3-kinase delta App 20050261317 - Sadhu, Chanchal ; et al.	2005-11-24
Compounds useful for inhibiting CHK1 App 20050245525 - Keegan, Kathleen S. ; et al.	2005-11-03
Inhibitors of human phosphatidyl-inositol 3-kinase delta Grant 6,949,535 - Sadhu , et al. September 27, 2	2005-09-27
Inhibitors of human phosphatidyl-inositol 3-kinase delta App 20040266780 - Sadhu, Chanchal ; et al.	2004-12-30
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 6,800,620 - Sadhu , et al. October 5, 2	2004-10-05
Cyclic AMP-specific phosphodiesterase inhibitors App 20040152754 - Martins, Timothy J. ; et al.	2004-08-05
Cyclic AMP-specific phosphodie sterase inhibitors Grant 6,716,871 - Martins , et al. April 6, 2	2004-04-06
Cyclic Amp-specific Phosphodiesterase Inhibitors App 20040023945 - Martins, Timothy J. ; et al.	2004-02-05
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 6,667,300 - Sadhu , et al. December 23, 2	2003-12-23
Inhibitors of human phosphatidylinositol 3-kinase delta App 20030195211 - Sadhu, Chanchal ; et al.	2003-10-16
Compounds useful for inhibiting Chk1 App 20030069284 - Keegan, Kathleen S. ; et al.	2003-04-10
Inhibitors of human phosphatidylinositol 3-kinase delta Grant 6,518,277 - Sadhu , et al. February 11, 2	2003-02-11
Materials and methods to potentiate cancer treatment App 20020165218 - Halbrook, James ; et al.	2002-11-07
Inhibitors of human phosphatidylinositol 3-kinase delta App 20020161014 - Sadhu, Chanchal ; et al.	2002-10-31
Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,458,787 - Martins , et al. October 1, 2	2002-10-01
Cyclic AMP-specific phosphodiesterase inhibitors Grant 6,423,710 - Martins , et al. July 23, 2	2002-07-23
Phenyldiboronic acid reagents and complexes Grant 6,124,471 - Stolowitz , et al. September 26, 2	2000-09-26
Phenyldiboronic acid reagents and complexes Grant 6,075,126 - Stolowitz , et al. June 13, 2	2000-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.